<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://mn.medsurfnews.com</link><description>Last resources from Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthwaregroup.com</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://mn.medsurfnews.com/images/logo.jpg</url><link>http://mn.medsurfnews.com</link></image>

	
	
<item>

<title>SSRIs and antiplatelets</title>
<link>http://mn.medsurfnews.com/contents/en/7305/display/ssris-and-antiplatelets.aspx</link>
<pubDate>Mon, 28 May 2012 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[The release of serotonin by platelets increases platelet aggregation at sites of endothelial damage, thus the reduction of intraplatelet serotonin by SSRIs should in theory decrease the effectiveness  of platelet aggregation. Following this assumption, a few observational studies reported an [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7305_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7305_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Selenium and lipid profile</title>
<link>http://mn.medsurfnews.com/contents/en/6942/display/selenium-and-lipid-profile.aspx</link>
<pubDate>Mon, 12 Dec 2011 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[It has been suggested that selenium may be able to inhibit lipid oxidation and reduce platelet aggregation and inflammation. Notwithstanding this, studies investigating the relationship between selenium and lipids have produced controversial results. For this reason, British investigators set up a [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6942_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6942_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Home Monitoring of INR</title>
<link>http://mn.medsurfnews.com/contents/en/6389/display/home-monitoring-of-inr.aspx</link>
<pubDate>Mon, 25 Apr 2011 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[The greatest problem in warfarin use is given by the need to monitor coagulation status with a certain frequency, so in the USA the possibility to control INR at home has been recently introduced. But is this practice safe, easily feasible and fit for all patients? In order to answer this question, [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6389_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6389_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Tranexamic Acid after Severe Injuries</title>
<link>http://mn.medsurfnews.com/contents/en/6082/display/tranexamic-acid-after-severe-injuries.aspx</link>
<pubDate>Mon, 20 Dec 2010 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[The use of tranexamic acid during surgeries is associated with less blood losses and less needs of transfusions. According to this statement, with a randomized trial, partly sponsored by pharmaceutical industry (CRASH-2: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6082_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6082_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Antiplatelet Drugs, Anticoagulants and Hemorrhagic Risk</title>
<link>http://mn.medsurfnews.com/contents/en/5414/display/antiplatelet-drugs-anticoagulants-and-hemorrhagic-risk.aspx</link>
<pubDate>Mon, 28 Jun 2010 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[After a myocardial infarction, the use of aspirin and clopidogrel is recommended, but many patients in this conditions also need a vitamin-K antagonist. But these drugs together cause an increase in hemorrhagic risk, even severe, and they consequently increase overall morbidity and mortality. In [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/5414_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/5414_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Natural History of Amyloidosis</title>
<link>http://mn.medsurfnews.com/contents/en/1791/display/natural-history-of-amyloidosis.aspx</link>
<pubDate>Mon, 7 Jan 2008 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[Systemic amyloidosis occurs in two main variations: AL (primary amyloidosis, associated with the presence of a monoclonal variation of plasmacells) and AA (amyloidosis secondary to chronic inflammatory diseases). Some English researchers belonging to the National Amyloidosis Centre have described [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/1791_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/1791_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Myelodysplastic Syndromes: Incidence And Survival</title>
<link>http://mn.medsurfnews.com/contents/en/1421/display/myelodysplastic-syndromes-incidence-and-survival.aspx</link>
<pubDate>Mon, 24 Sep 2007 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[Myelodysplastic syndromes (MDS) are a group of marrow diseases including refractory anemia, refractory anemia with ring sideroblast and refractory anemia with excessive blast. There can be leucopenia or thrombocytopenia, beside the usual anemia, which can possibly turn into acute leukemias. In this [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/1421_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/1421_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Thrombocytopenia and Vancomycin</title>
<link>http://mn.medsurfnews.com/contents/en/1365/display/thrombocytopenia-and-vancomycin.aspx</link>
<pubDate>Mon, 2 Jul 2007 12:00:00 +0200</pubDate>
<category>Hematology</category>
<description><![CDATA[Even if cases of vancomycin-induced thrombocytopenia have been reported, it is not clear yet which is the mechanism at the basis of this association. Now, antibodies G and M have been studied in 29 patients with anamnesis suggesting vancomycin-induced thrombocytopenia (these antibodies were neither [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/1365_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/1365_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	</channel></rss>
	



